Prostaglandins E1 and E2 inhibit lipopolysaccharide-induced interleukin-18 production in monocytes
- 11 July 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 517 (3) , 252-256
- https://doi.org/10.1016/j.ejphar.2005.05.020
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- E-Prostanoid (EP)2/EP4 Receptor-Dependent Maturation of Human Monocyte-Derived Dendritic Cells and Induction of Helper T2 PolarizationThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Prostaglandin E2 Inhibits IL-18-Induced ICAM-1 and B7.2 Expression Through EP2/EP4 Receptors in Human Peripheral Blood Mononuclear CellsThe Journal of Immunology, 2002
- Acute Toxoplasmosis Leads to Lethal Overproduction of Th1 CytokinesThe Journal of Immunology, 2001
- IFN-γ-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12The Journal of Immunology, 2000
- Neutralization of IL-18 Reduces Neutrophil Tissue Accumulation and Protects Mice Against Lethal Escherichia coli and Salmonella typhimurium EndotoxemiaThe Journal of Immunology, 2000
- Prostanoid Receptors: Structures, Properties, and FunctionsPhysiological Reviews, 1999
- Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial CellsBlood, 1998
- Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsisJournal of Laboratory and Clinical Medicine, 1996
- ASSESSMENT OF TWO CLINICAL TRIALSShock, 1996
- Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.Proceedings of the National Academy of Sciences, 1995